At a recent conference, executives from across the industry shared their thoughts on how the healthcare sector can ensure its use of AI is ethical and responsible. They highlighted the need for collaboration, trust building and pragmatic thinking.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
During an interview this month at HIMSS24, David Vawdrey — Geisinger’s chief data and informatics officer — said health systems should spend more time designing their plan for evaluating success when it comes to tech pilots.
Geisinger is launching a pilot program in partnership with virtual heart failure monitoring startup Bodyport. About 200 of the health system's heart failure patients will be using Bodyport’s cardiac scale at home — the scale uses sensors to measure a person’s metrics of heart function and body fluid status after they stand on it for about 20 seconds.
Executives from Geisinger and UNC Health discussed the most impactful ways they have deployed predictive AI across their health systems during a recent virtual panel. At Geisinger, these predictive algorithms are reducing avoidable emergency department admissions, and at UNC, they are helping to identify sepsis before it becomes severe.
M&A activity among hospitals and health systems increased in Q2 of 2023 — there were 20 deals in Q2 compared to 15 deals in Q1, according to a new report. This surge brought Q2’s M&A activity levels in line with those observed before the pandemic. Q2’s 20 deal marks the highest number of announced transactions for hospitals and health systems since Q1 of 2020.
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
Avia CEO Linda Finkel has had many conversations with health systems executives about why their technology initiatives haven’t gone as planned in the past. Based on these experiences, she has noticed four main reasons hospitals don’t see the results for which they were hoping — including not exercising enough scrutiny during the vendor selection process and failure to think about capability at scale.
Price transparency data has revealed there is a high degree of price variance for healthcare procedures depending on patients' insurance carriers and the location in which services are delivered. Jaewon Ryu, Geisinger’s president and CEO, said that the only way this variability can be addressed is by getting decision makers on the payment side much more aligned with the care delivery side of things.
Dr. Shafiq Rab and John Kravitz, executives at Tufts Medicine and Geisinger, said AWS will offer them better connectivity speed and business continuity than other cloud vendors.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Feinberg comes to Cerner from Google Health, which he has led since 2019. The move comes amid news reports that Google plans to dismantle its health division, though the company denies any such plans.
SDoH is just one of the topics at the MedCity INVEST Digital Health conference, a virtual event scheduled for September 20-23, in collaboration with Medical Alley.
Developed by Noteworth, the ConnectedCare365 application will enable Geisinger clinicians to virtually monitor patient vital signs and intervene when needed. The platform will be used for several clinical initiatives, including chronic condition management and behavioral health.
Geisinger and Siemens Healthineers struck a 10-year partnership. The agreement will give Geisinger access to Siemens’ diagnostic imaging equipment and digital health tools.
The company has a 10,000-patient prospective trial with Geisinger fully enrolled to test CancerSEEK, a test developed at Johns Hopkins University.
